At the 2021 Society of Hematologic Oncology Annual Meeting, Bijal Shah, MD, MS, of Moffitt Cancer Center, discussed what to expect going forward in the field of acute lymphoblastic leukemia.
Post Tags:SOHO21
Related Posts
FDA shifts to real-time FAERS reporting, aiming to boost transparency in drug safety but raising concerns on data use.
Cardiovascular complications, such as those associated with arterial or venous thromboembolism, are a prominent concern.
Naval Daver, MD reviews new immunotherapy and targeted strategies transforming ALL treatment and outcomes.
The name change will take effect on August 28, ahead of Blood Cancer Awareness Month in September.
Guest contributor Moaath Mustafa Ali, MD, MPH, outlines the transforming treatment paradigm of Ph+ ALL.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.